Top

BMC Geriatrics

Published in:

Open Access 01-12-2024 | Research

Influence of chronic medical conditions on older patients’ willingness to deprescribe medications: a cross-sectional study

Authors: Anabela Pereira, Manuel Veríssimo, Oscar Ribeiro

Published in: BMC Geriatrics | Issue 1/2024

Abstract

Background

Aging correlates with a heightened prevalence of chronic diseases, resulting in multimorbidity affecting 60% of those aged 65 or older. Multimorbidity often leads to polypharmacy, elevating the risk of potentially inappropriate medication (PIM) use and adverse health outcomes. To address these issues, deprescribing has emerged as a patient-centered approach that considers patients’ beliefs and attitudes toward medication and reduces inappropriate polypharmacy in older adults. Our study aims to investigate whether certain chronic medical conditions are associated with older patients’ willingness to deprescribe medications.

Methods

A cross-sectional study enrolled 192 community-dwelling individuals aged 65 or older taking at least one regular medication. Data included demographics, clinical characteristics, and responses to the Portuguese revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire. Descriptive statistics characterized participants, while multiple binary logistic regression identified associations between chronic medical conditions and willingness to deprescribe.

Results

Among the participants (median age: 72 years, 65.6% female), 91.6% had multimorbidity. The analysis revealed that willingness to deprescribe significantly increased with the presence of gastric disease (adjusted odds ratio [aOR] = 4.123; 95% CI 1.221, 13.915) and age (aOR = 1.121; 95% CI 1.009, 1.246). Conversely, prostatic pathology (aOR = 0.266; 95% CI 0.077, 0.916), higher scores in the rPATD appropriateness factor (aOR = 0.384; 95% CI 0.190, 0.773), and rPATD concerns about stopping factor (aOR = 0.450; 95% CI 0.229, 0.883) diminished patients’ willingness to deprescribe.

Conclusions

This study highlights the intricate relationship between older patients’ attitudes toward deprescribing and chronic medical conditions. We found that gastric disease was associated with an increased willingness to deprescribe medications, while prostate disease was associated with the opposite effect. Future research should explore how patients with specific diseases or groups of diseases perceive deprescribing of medications general and for specific medications, aiding in the development of targeted interventions.

Available only for authorised users

Eurostat. Proportion of population aged 65 and over: European Comission; 2023 [updated 22/06/2022. Available from: https://ec.europa.eu/eurostat/databrowser/view/TPS00028/default/bar?lang=en&category=demo.demo_ind

Eurostat. Ageing Europe - statistics on population developments. 2020.

Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374(9696):1196–208. https://doi.org/10.1016/s0140-6736(09)61460-4CrossRefPubMedPubMedCentral

Atella V, Piano Mortari A, Kopinska J, Belotti F, Lapi F, Cricelli C, et al. Trends in age-related disease burden and healthcare utilization. Aging Cell. 2019;18(1):e12861. https://doi.org/10.1111/acel.12861CrossRefPubMed

Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity Nat Reviews Disease Primers. 2022;8(1):48. https://doi.org/10.1038/s41572-022-00376-4CrossRefPubMed

Payne RA, Avery AJ, Duerden M, Saunders CL, Simpson CR, Abel GA. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol. 2014;70(5):575–81. https://doi.org/10.1007/s00228-013-1639-9CrossRefPubMed

Aubert CE, Streit S, Da Costa BR, Collet TH, Cornuz J, Gaspoz JM, et al. Polypharmacy and specific comorbidities in university primary care settings. Eur J Intern Med. 2016;35:35–42. https://doi.org/10.1016/j.ejim.2016.05.022CrossRefPubMed

Gallacher KI, Batty GD, McLean G, Mercer SW, Guthrie B, May CR, et al. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden. BMC Med. 2014;12(1). https://doi.org/10.1186/s12916-014-0151-0

Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–95. https://doi.org/10.1016/j.cger.2012.01.006CrossRefPubMed

10.

Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):12. https://doi.org/10.1186/s12877-022-03279-xCrossRef

11.

Midão L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213–20. https://doi.org/10.1016/j.archger.2018.06.018CrossRefPubMed

12.

Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS ONE. 2021;16(8):10. https://doi.org/10.1371/journal.pone.0255642CrossRef

13.

WHO. Medication safety in polypharmacy: technical report. [Technical report]. Geneva: World Health Organization. 2019. Available from: https://apps.who.int/iris/handle/10665/325454

14.

Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. https://doi.org/10.1517/14740338.2013.827660CrossRefPubMed

15.

Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71(12):1415–27. https://doi.org/10.1007/s00228-015-1954-4CrossRefPubMed

16.

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. https://doi.org/10.1186/s12877-017-0621-2CrossRefPubMedPubMedCentral

17.

Fried TR, O’Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261–72. https://doi.org/10.1111/jgs.13153CrossRefPubMedPubMedCentral

18.

Gutiérrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero Á, Inzitari M, Martínez-Velilla N. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84(7):1432–44. https://doi.org/10.1111/bcp.13590CrossRefPubMedPubMedCentral

19.

Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85(1):86–8. https://doi.org/10.1038/clpt.2008.224CrossRefPubMed

20.

Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68. https://doi.org/10.1111/bcp.12732CrossRefPubMedPubMedCentral

21.

Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016:583–623. https://doi.org/10.1111/bcp.12975

22.

Reeve E, Thompson W, Farrell B, Deprescribing. A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017;38:3–11. https://doi.org/10.1016/j.ejim.2016.12.021CrossRefPubMed

23.

Kua CH, Mak VSL, Huey Lee SW. Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc. 2019;20(3):362–72 e11. https://doi.org/10.1016/j.jamda.2018.10.026CrossRefPubMed

24.

Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28(2):237–53. https://doi.org/10.1016/j.cger.2012.01.006CrossRefPubMed

25.

Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C, et al. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open. 2015;5(12):e009235. https://doi.org/10.1136/bmjopen-2015-009235CrossRefPubMedPubMedCentral

26.

Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738–47. https://doi.org/10.1111/bcp.12386CrossRefPubMedPubMedCentral

27.

Jansen J, Naganathan V, Carter SM, McLachlan AJ, Nickel B, Irwig L, et al. Too much medicine in older people? Deprescribing through shared decision making. Bmj-British Med J. 2016;353. https://doi.org/10.1136/bmj.i2893

28.

Weir KR, Ailabouni NJ, Schneider CR, Hilmer SN, Reeve E. Consumer attitudes towards deprescribing: a systematic review and meta-analysis. Journals Gerontol Ser Biol Sci Med Sci. 2021. https://doi.org/10.1093/gerona/glab222CrossRef

29.

Pereira A, Ribeiro O, Veríssimo M. Predictors of older patients’ willingness to have medications deprescribed: a cross-sectional study. Basic Clin Pharmacol Toxicol. 2023;133(6):703–17. https://doi.org/10.1111/bcpt.13874

30.

Reeve E, Low LF, Hilmer SN. Attitudes of older adults and caregivers in Australia toward deprescribing. J Am Geriatr Soc. 2019;67(6):1204–10. https://doi.org/10.1111/jgs.15804CrossRefPubMed

31.

Shrestha S, Giri R, Sapkota HP, Danai SS, Saleem A, Devkota S, et al. Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe. Therapeutic Adv drug Saf. 2021;12:20420986211019309. https://doi.org/10.1177/20420986211019309CrossRef

32.

Buzancic I, Dragovic P, Pejakovic TI, Markulin L, Ortner-Hadziabdic M. Exploring patients’ attitudes toward deprescribing and their perception of pharmacist involvement in a European country: a cross-sectional study. Patient Prefer Adherence. 2021;15:2197–208. https://doi.org/10.2147/ppa.S323846CrossRefPubMedPubMedCentral

33.

Hao LJ, Omar MS, Tohit N. Polypharmacy and willingness to deprescribe among elderly with chronic diseases. Int J Gerontol. 2018;12(4):340–3. https://doi.org/10.1016/j.ijge.2018.05.006CrossRef

34.

Ng WL, Tan MZW, Koh EYL, Tan NC. Deprescribing: what are the views and factors influencing this concept among patients with chronic diseases in a developed Asian community? Proceedings of Singapore Healthcare. 2017;26(3):172-9. https://doi.org/10.1177/2010105817699633

35.

Aoki T, Yamamoto Y, Ikenoue T, Fukuhara S. Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications. Int J Clin Pharm. 2019;41(2):531–7. https://doi.org/10.1007/s11096-019-00797-4CrossRefPubMed

36.

Kua KP, Saw PS, Lee SWH. Attitudes towards deprescribing among multi-ethnic community-dwelling older patients and caregivers in Malaysia: a cross-sectional questionnaire study. Int J Clin Pharm. 2019;41(3):793–803. https://doi.org/10.1007/s11096-019-00829-zCrossRefPubMed

37.

Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM. Assessment of attitudes toward deprescribing in older medicare beneficiaries in the United States. Jama Intern Med. 2018;178(12):1673–80. https://doi.org/10.1001/jamainternmed.2018.4720CrossRefPubMedPubMedCentral

38.

Reeve E, Bayliss EA, Shetterly S, Maiyani M, Gleason KS, Norton JD, et al. Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed. Age Ageing. 2023;52(1). https://doi.org/10.1093/ageing/afac335

39.

Kua C-H, Reeve E, Tan DSY, Koh T, Soong JL, Sim MJL et al. Patients’ and caregivers’ attitudes toward deprescribing in Singapore. The journals of gerontology Series A, Biological sciences and medical sciences. 2020. https://doi.org/10.1093/gerona/glaa062

40.

Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61(9):1508–14. https://doi.org/10.1111/jgs.12418CrossRefPubMed

41.

Hanna V, Chahine B, Al Souheil F. Attitudes of Lebanese community-dwelling older adults towards deprescribing using the rPATD tool. Arch Gerontol Geriatr. 2023;105:6. https://doi.org/10.1016/j.archger.2022.10484CrossRef

42.

Crutzen S, Abou J, Smits SE, Baas G, Hugtenburg JG, Heringa M, et al. Older people’s attitudes towards deprescribing cardiometabolic medication. BMC Geriatr. 2021;21(1):366. https://doi.org/10.1186/s12877-021-02249-zCrossRefPubMedPubMedCentral

43.

Qi K, Reeve E, Hilmer SN, Pearson SA, Matthews S, Gnjidic D. Older peoples’ attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. Int J Clin Pharm. 2015;37(5):949–57. https://doi.org/10.1007/s11096-015-0147-7CrossRefPubMed

44.

Long E, Ponder M, Bernard S. Knowledge, attitudes, and beliefs related to hypertension and hyperlipidemia self-management among African-American men living in the southeastern United States. Patient Educ Couns. 2017;100(5):1000–6. https://doi.org/10.1016/j.pec.2016.12.011CrossRefPubMed

45.

Pereira A, Ribeiro Ó, Veríssimo M. Translation, cross-cultural adaptation and validation of the revised patients’ attitudes towards deprescribing (rPATD) questionnaire to Portuguese: older adults version. Res Social Administrative Pharm. 2022. https://doi.org/10.1016/j.sapharm.2022.08.015CrossRef

46.

Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.CrossRefPubMed

47.

Reeve E, Low LF, Shakib S, Hilmer SN. Development and validation of the revised patients’ attitudes towards deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33(12):913–28. https://doi.org/10.1007/s40266-016-0410CrossRefPubMed

48.

Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies - development and validation. J Chronic Dis. 1987;40(5):373–83. https://doi.org/10.1016/0021-9681(87)90171-8CrossRefPubMed

49.

Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18(6):805–35. https://doi.org/10.1097/EDE.0b013e3181577511CrossRefPubMed

50.

Edelman M, Blanker M, Jellema P, Hak E, Denig P. Patient attitudes towards deprescribing of alpha-blockers and willingness to participate in a discontinuation trial. Neurourol Urodyn. 2017;36:S242–4. https://doi.org/10.1007/s40266-019-00712-6CrossRef

51.

Emberton M, Marberger M, de la Rosette J. Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: the prostate research on behaviour and education (PROBE) survey. Int J Clin Pract. 2008;62(1):18–26. https://doi.org/10.1111/j.1742-1241.2007.01635.xCrossRefPubMed

52.

Teillac P. [Benign prostatic hyperplasia: patients’ perception of medical treatment and their expectations. Results of a French survey involving patients treated with finasteride]. Therapie. 2002;57(5):473–83.PubMed

53.

Weibl P, Klatte T, Laurinc P, Tomaškin R, Shariat SF, Helbich M, et al. Patient’s behavior and attitudes toward the management of benign prostatic hyperplasia among patients with the risk of disease progression: prospective study by prostate and expectations of treatment epidemiology research (PETER) study group. Wien Klin Wochenschr. 2015;127(9–10):363–8. https://doi.org/10.1007/s00508-014-0668-4CrossRefPubMed

54.

Huffman PJ, Yin E, Cohen AJ. Evaluating patient preferences in benign prostatic hyperplasia treatment using conjoint analysis. Urology. 2022;164:211–7. https://doi.org/10.1016/j.urology.2022.01.012CrossRefPubMed

55.

Mohammed MA, Harrison J, Milosavljevic A, Chan AHY. Attitude towards deprescribing and its association with frailty and complexity of medication regimen: a survey of older inpatients in a district health board in New Zealand. BMC Geriatr. 2023;23(1):166. https://doi.org/10.1186/s12877-023-03878-2CrossRefPubMedPubMedCentral

56.

Gadisa DA, Gebremariam ET, Yimer G, Urgesa ED. Attitudes of older adult patients and caregivers towards deprescribing of medications in Ethiopia. Clin Interv Aging. 2023;18:1129–43. https://doi.org/10.2147/CIA.S400698CrossRefPubMedPubMedCentral

57.

Roux B, Rakheja B, Sirois C, Niquille A, Petein C, Ouellet N, et al. Attitudes and beliefs of older adults and caregivers towards deprescribing in french-speaking countries: a multicenter cross-sectional study. Eur J Clin Pharmacol. 2022. https://doi.org/10.1007/s00228-022-03368-1CrossRefPubMed

58.

Oktora MP, Yuniar CT, Amalia L, Abdulah R, Hak E, Denig P. Attitudes towards deprescribing and patient-related factors associated with willingness to stop medication among older patients with type 2 diabetes (T2D) in Indonesia: a cross-sectional survey study. BMC Geriatr. 2023;23(1). https://doi.org/10.1186/s12877-022-03718-9

59.

Lukacena KM, Keck JW, Freeman PR, Harrington NG, Huffmyer MJ, Moga DC. Patients’ attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists. Therapeutic Adv Drug Saf. 2022;13:11. https://doi.org/10.1177/20420986221116465CrossRef

60.

PORDATA. Resident population aged 65 and over, total and by age group. Pordata; [cited 2024 Feb 20]. Available from: https://www.pordata.pt/portugal/populacao+residente+com+65+e+mais+anos+total+e+por+grupo+etario-3508

61.

PORDATA. Resident population aged 16 to 64 years and 65 to 89 years by highest completed educational level. Pordata; [cited 2024 Feb 20]. Available from: https://www.pordata.pt/portugal/populacao+residente+com+16+a+64+anos+e+65+a+89+anos+por+nivel+de+escolaridade+completo+mais+elevado-332

62.

Mackenbach JP, Stirbu I, Roskam AJ, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;358(23):2468–81. https://doi.org/10.1056/NEJMsa0707519CrossRefPubMed

Title: Influence of chronic medical conditions on older patients’ willingness to deprescribe medications: a cross-sectional study
Authors: Anabela Pereira
Manuel Veríssimo
Oscar Ribeiro
Publication date: 01-12-2024
Publisher: BioMed Central
Published in: BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI: https://doi.org/10.1186/s12877-024-04891-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Aging with my family: a grounded theory approach on the role of family when aging as foreign-born

Increased serum methylmalonic acid levels were associated with the presence of cognitive dysfunction in older chronic kidney disease patients with albuminuria

Lifestyle patterns, nutritional, and metabolic syndrome determinants in a sample of the older Iranian population

Using a mobile application to reduce potentially inappropriate prescribing for older Brazilian adults in primary care: a triple-blind randomised clinical trial

Reasons for hospitalisation and cumulative mortality in people, 75 years or older, at high risk of hospital admission: a prospective study

Association between plasma metal exposure and health span in very elderly adults: a prospective cohort study with mixture statistical approach

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials